HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sylvie G Bernier Selected Research
Sylvie G Bernier Research Topics
Disease
8
Inflammation (Inflammations)
09/2021 - 10/2003
3
Fibrosis (Cirrhosis)
01/2020 - 01/2018
2
Heart Failure
01/2020 - 01/2018
2
Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2018
2
Rheumatoid Arthritis
01/2015 - 07/2004
2
Arthritis (Polyarthritis)
03/2007 - 07/2004
2
Neoplasms (Cancer)
04/2006 - 10/2003
1
Neuroinflammatory Diseases
09/2021
1
Sickle Cell Anemia (Hemoglobin S Disease)
01/2021
1
Pulmonary Hypertension
01/2021
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1
Drug-Related Side Effects and Adverse Reactions
01/2021
1
Alzheimer Disease (Alzheimer's Disease)
01/2021
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020
1
Liver Diseases (Liver Disease)
01/2019
1
Non-alcoholic Fatty Liver Disease
01/2019
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2019
1
Proteinuria
01/2018
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2018
1
Hypertension (High Blood Pressure)
01/2018
1
Ureteral Obstruction
01/2018
1
Castleman Disease (Castleman's Disease)
01/2015
1
Multiple Sclerosis
10/2013
1
Hypersensitivity (Allergy)
09/2013
1
Pain (Aches)
09/2013
1
Lymphopenia (Lymphocytopenia)
04/2009
1
Osteitis
03/2007
1
Bone Resorption
03/2007
1
Experimental Arthritis
03/2007
1
Melanoma (Melanoma, Malignant)
04/2006
1
Carcinoma (Carcinomatosis)
08/2005
1
Chronic Disease (Chronic Diseases)
07/2004
1
Seizures (Absence Seizure)
07/2004
1
Hepatocellular Carcinoma (Hepatoma)
10/2003
1
Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
04/2003
1
Necrosis
10/2002
1
Acidosis
05/2002
1
Hyperemia
05/2002
1
Hypercapnia
05/2002
Drug/Important Bio-Agent (IBA)
7
Soluble Guanylyl Cyclase
IBA
09/2021 - 01/2018
4
Nitric Oxide (Nitrogen Monoxide)
FDA Link
09/2021 - 01/2018
4
Methionine (L-Methionine)
FDA Link
03/2007 - 07/2004
3
PPI 2458
IBA
03/2007 - 07/2004
2
Lipopolysaccharides
IBA
09/2021 - 01/2018
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2019
2
Salts
IBA
01/2020 - 01/2018
2
praliciguat
IBA
01/2019 - 01/2018
2
Peptidoglycan (Murein)
IBA
03/2007 - 07/2004
2
Aminopeptidases
IBA
03/2007 - 08/2005
2
Polysaccharides (Glycans)
IBA
03/2007 - 07/2004
2
methionine aminopeptidase 2
IBA
04/2006 - 08/2005
2
Proteins (Proteins, Gene)
FDA Link
08/2005 - 05/2002
1
Neuroprotective Agents
IBA
09/2021
1
Guanosine Monophosphate (5' Guanylic Acid)
IBA
09/2021
1
Quinolinic Acid
IBA
09/2021
1
Phosphoric Diester Hydrolases (Phosphodiesterases)
IBA
01/2021
1
Carboxylic Acids
IBA
01/2021
1
Glucuronides
IBA
01/2021
1
Donepezil (Aricept)
FDA Link
Generic
01/2021
1
Glucose (Dextrose)
FDA Link
Generic
01/2020
1
Triglycerides (Triacylglycerol)
IBA
01/2020
1
Cholesterol
IBA
01/2020
1
Elements
IBA
01/2019
1
azastene
IBA
01/2018
1
Cytokines
IBA
01/2018
1
Interleukin-6 (Interleukin 6)
IBA
01/2015
1
Prodrugs
IBA
10/2013
1
Sphingosine-1-Phosphate Receptors
IBA
10/2013
1
Amino Alcohols
IBA
10/2013
1
Guanylate Cyclase (Guanylyl Cyclase)
IBA
09/2013
1
Hormones (Hormone)
IBA
09/2013
1
uroguanylin
IBA
09/2013
1
Sulfonic Acids
IBA
09/2013
1
guanylin
IBA
09/2013
1
carbamic acid (ammonium carbamate)
IBA
03/2007
1
Esters
IBA
03/2007
1
Enzymes
IBA
04/2006
1
fumagillin
IBA
04/2006
1
Small Interfering RNA (siRNA)
IBA
08/2005
1
O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)
IBA
07/2004
1
lysophosphatidic acid
IBA
10/2003
1
Antibodies
IBA
10/2003
1
Oxidants (Oxidizing Agents)
IBA
04/2003
1
Niacinamide (Nicotinamide)
FDA Link
Generic
10/2002
1
Caspase Inhibitors
IBA
10/2002
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
10/2002
1
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
IBA
10/2002
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
10/2002
1
benzoylcarbonyl- aspartyl- glutamyl- valyl- aspartyl- fluoromethyl ketone
IBA
10/2002
1
Prostaglandins
IBA
05/2002
1
Retinaldehyde (Retinal)
IBA
05/2002
1
NADPH Dehydrogenase (Dehydrogenase, NADP)
IBA
05/2002
1
NADP (NADPH)
IBA
05/2002
1
Diclofenac (SR 38)
FDA Link
Generic
05/2002
1
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
05/2002
1
Nitrites
IBA
05/2002
Therapy/Procedure
1
Therapeutics
01/2019
1
Oral Administration
04/2009
1
Molecular Targeted Therapy
03/2007
1
Microspheres (Microsphere)
05/2002